Advanced Medical Optics (EYE) Tops Q4 Views
Advanced Medical Optics, Inc. (NYSE: EYE) reports Q4 EPS of $0.17, ex-items, 3 cents better than the analyst estimate of $0.14. Revenues for the quarter were $285.2 million, versus the consensus of $282.87 million.
On January 12, 2009, AMO and Abbott (NYSE: ABT) announced a definitive agreement for Abbott to acquire AMO for $22 per share in cash, for a total transaction value of approximately $2.8 billion, inclusive of estimated net debt at the time of close. The transaction is expected to close in the first quarter of 2009.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
